Primary Screening with Colonoscopy for Colorectal Cancer: A Targeted Algorithm?

American Journal of Gastroenterology

Volumn 98, Issue 12, 2003, Pages 2587-2589

  Byrne, Michael F ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADVANCED CANCER; AGED; ALGORITHM; BARIUM ENEMA; BODY MASS; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DYSPLASIA; ECONOMIC ASPECT; EDITORIAL; GENE MUTATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HIGH RISK POPULATION; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MALE; MASS SCREENING; MEDICAL STAFF; MEDICARE; MORBIDITY; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT SELECTION; PILOT STUDY; POLYPECTOMY; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; SEX DIFFERENCE; SIGMOIDOSCOPY; TUMOR CELL; VALIDATION PROCESS;

EID: 0346734218     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08774.x     Document Type: Editorial

References (31)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):S4-66.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
5. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
6. Selby JV, Friedman GD, Quesenberry CP, Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
7. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
8. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
9. Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5.
10. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
11. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
12. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
13. Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003;98:2648-54.
14. Detsky AS. Screening for colon cancer - can we afford colonoscopy? N Engl J Med 2001;345:607-8.
15. Rhodes JM. Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland. Gut 2000;46:746-8.
16. Atkin WS, Edwards R, Wardle J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44.
17. Rozen P, Winawer SJ, Waye JD. Prospects for the worldwide control of colorectal cancer through screening. Gastrointest Endosc 2002;55:755-9.
18. Pedersen KE, Elwood M. Current international developments in population screening for colorectal cancer. ANZ J Surg 2002;72:507-12.
19. Rex DK. Sigmoidoscopy or colonoscopy: Which way are we headed? Am J Gastroenterol 2000;95:1116-8.
20. Podolsky DK. Going the distance - the case for true colorectal-cancer screening. N Engl J Med 2000;343:207-8.
21. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
22. Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: A framework for action: The strategic plan of the National Colorectal Cancer Roundtable. Cancer 2002;95:1618-28.
23. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133:573-84.
24. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-61.
25. Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am 2002;12:93-109.
26. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 2002;162:163-8.
27. Barry MJ. Fecal occult blood testing for colorectal cancer: A perspective. Ann Oncol 2002;13:61-4.
28. Kee F, Wilson RH, Gilliland R, et al. Changing site distribution of colorectal cancer. BMF 1992;305:158.
29. Nelson RL, Persky V, Turyk M. Time trends in distal colorectal cancer subsite location related to age and how it affects choice of screening modality. J Surg Oncol 1998;69:235-8.
30. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
31. Traverso G, Shuber A, Olsson L, et al. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 2002;359:403-4.